Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part II - preanalytical issues.

Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part II - preanalytical issues.

Item
http://www.wikidata.org/entity/Q38136149
Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary ImmunodeficienciesData quality in drug discovery: the role of analytical performance in ligand binding assays.Toward the harmonization of result presentation for the eosin-5'-maleimide binding test in the diagnosis of hereditary spherocytosis.A QA program for MRD testing demonstrates that systematic education can reduce discordance among experienced interpreters.Diagnosis of chronic lymphoproliferative disorders by flow cytometry using four-color combinations for immunophenotyping: A proposal of the Brazilian Group of Flow Cytometry (GBCFLUX).Report of the results of the international clinical cytometry society and american society for clinical pathology workload survey of clinical flow cytometry laboratories.2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity).Validation of a flow cytometry-based assay to assess C5aR receptor occupancy on neutrophils and monocytes for use in drug development.Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms.Regulatory perspective on minimal residual disease flow cytometry testing in multiple myeloma.Methods of Detection of Measurable Residual Disease in AML.Fifty years of the ICSH: 1964 to 2014.Initial flow cytometric evaluation of the Clearllab lymphoid screen.Assembly and evaluation of an inventory of guidelines that are available to support clinical hematology laboratory practice.Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry.Expression of Bruton's tyrosine kinase in B-cell neoplasms evaluated by flow cytometry.Increased expression of brother of the regulator of imprinted sites in peripheral blood neutrophils is associated with both benign and malignant breast lesions.
P2860

Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part II - preanalytical issues.

Item
http://www.wikidata.org/entity/Q38136149
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Validation of cell-based fluor ...... art II - preanalytical issues.
@en
type
label
Validation of cell-based fluor ...... art II - preanalytical issues.
@en
prefLabel
Validation of cell-based fluor ...... art II - preanalytical issues.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Validation of cell-based fluor ...... art II - preanalytical issues.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698